Ayuk Paul T-Y, Matijevic Ratko
Nuffield Department of Obstetrics and Gynaecology, Women' Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom.
Med Hypotheses. 2006;67(4):792-5. doi: 10.1016/j.mehy.2006.04.026. Epub 2006 Jun 9.
The aetiology or pre-eclampsia remains unknown, but it is widely accepted that the disorder is placental in origin. Failed trophoblast invasion of the maternal spiral arteries is accepted to be a central pathogenetic mechanism. However, the concept of failed trophoblast invasion is based on an assumption rather than direct scientific observation and there are other likely explanations for this phenomenon. The criteria for disease causation, such as the Bradford-Hill criteria are central to the ascertainment of causal relationships in modern medicine and these criteria are used here to assess the relationship between the placenta and pre-eclampsia. There is a strong association between pre-eclampsia and small (rather than large) placentas and an appropriate dose-response relationship does not exist. Failed trophoblast invasion of the spiral arteries is not specific to pre-eclampsia and occurs in other pregnancy complications and in up to 40% of biopsies from normal pregnancies and the relationship between placental ischaemia and pre-eclampsia is very inconsistent. A placental cause for pre-eclampsia is not consistent with the pathogenesis of other pregnancy complications like gestational diabetes mellitus. If pre-eclampsia was a disease of trophoblast origin, the risk of the disease should be determined by trophoblast rather than maternal factors. However, evidence from assisted reproduction shows that the risk of a woman developing pre-eclampsia is almost entirely dependent on maternal factors and independent of the embryo from which the placenta develops. There is currently no plausible proven mechanism by which the placenta causes pre-eclampsia. The syndrome typically gets worse, and can arise de-novo after the placenta has been removed, calling into question the role of the placenta in its causation. Uterine artery ligation in humans, unlike in animal experiments, is not associated with an increased incidence of pre-eclampsia, calling into question the role of poor utero-placental perfusion in the cause of the disease in humans. The signals that initiate maternal adaptive responses during pregnancy come from or through the placenta into the maternal milieu but as is the case with gestational diabetes mellitus, are not necessarily the cause of maternal disease. Pre-eclampsia causes renal, hepatic, myocardial, cerebral and adrenal ischaemia--that is ischaemia in all highly vascular organs. Placental ischaemia, like ischaemia in all other organs, is a consequence rather than a causal factor in the development of the syndrome and this has profound consequences for research strategies.
先兆子痫的病因尚不清楚,但人们普遍认为该病症起源于胎盘。滋养层细胞对母体螺旋动脉的侵入失败被认为是一个核心致病机制。然而,滋养层细胞侵入失败的概念基于一种假设而非直接的科学观察,对此现象还有其他可能的解释。疾病因果关系的判定标准,如布拉德福德 - 希尔标准,是现代医学确定因果关系的核心,本文将用这些标准来评估胎盘与先兆子痫之间的关系。先兆子痫与小胎盘(而非大胎盘)之间存在很强的关联,且不存在适当的剂量反应关系。螺旋动脉的滋养层细胞侵入失败并非先兆子痫所特有,在其他妊娠并发症以及高达40%的正常妊娠活检中也会出现,而且胎盘缺血与先兆子痫之间的关系非常不一致。先兆子痫的胎盘病因与其他妊娠并发症(如妊娠期糖尿病)的发病机制不一致。如果先兆子痫是一种起源于滋养层细胞的疾病,那么该疾病的风险应由滋养层细胞而非母体因素决定。然而,辅助生殖的证据表明,女性患先兆子痫的风险几乎完全取决于母体因素,与胎盘发育所源自的胚胎无关。目前尚无合理的、已被证实的机制表明胎盘会导致先兆子痫。该综合征通常会恶化,并且在胎盘被移除后可能会新发,这让人质疑胎盘在其病因中的作用。与动物实验不同,人类子宫动脉结扎与先兆子痫发病率增加无关,这让人质疑子宫 - 胎盘灌注不良在人类该疾病病因中的作用。孕期启动母体适应性反应的信号来自胎盘或通过胎盘进入母体环境,但与妊娠期糖尿病一样,不一定是母体疾病的病因。先兆子痫会导致肾脏、肝脏、心肌、大脑和肾上腺缺血,即所有高血管器官的缺血。胎盘缺血与所有其他器官的缺血一样,是该综合征发展的结果而非因果因素,这对研究策略有着深远的影响。